Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that the meeting of the Board of Directors of the Company will be held on Wednesday, 19th July 2017, to consider the Unaudited financial results for the quarter and half year ended 30th June 2017 (Q2), Interim Dividend for the financial year ending on 31st December 2017.
The above information is a part of company’s filings submitted to BSE.